CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

Observational Study to Advance Genetic Understanding of FTD Being Conducted With Support From Alector

CAMBRIDGE, Mass. and ROSTOCK, Germany and…

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 1, 2020 (GLOBE NEWSWIRE)

  • World leader and trusted partner in rare diseases releases enhanced…

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 26, 2020 (GLOBE NEWSWIRE) - Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on…

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 18, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on…

Providing patients with genetic testing designed to accelerate the diagnosis and personalized treatment of Parkinson’s disease (PD)

CENTOGENE’s rare disease mutation database offers new features and previously unpublished variants

Research leads to diagnosis and treatment options for rare disease patients

Delivers very strong financial results in unprecedented year

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 14, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused…

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, April 8, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused…

For Further Inquiries Please Contact

Press Contact

Melissa Hall

Corporate Communications

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads